Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

Tortorella C;Aiello A;Gasperini C;Agrati C;Castilletti C;Ruggieri S;Meschi S;Matusali G;Colavita F;Farroni C;Cuzzi G;Cimini E;Tartaglia E;Vanini V;Prosperini L;Haggiag S;Galgani S;Quartuccio ME;Salmi A;Repele F;Gerarda Altera AM;Cristofanelli F;D'Abramo A;Bevilacqua N;Corpolongo A;Puro V;Vaia F;Capobianchi MR;Ippolito G;Nicastri E;Goletti D;INMI COVID-19 Vaccine Study Group.

2021-01-01